David RP Almeida, MD MBA PhD, is a Board-Certified Ophthalmologist and Vitreoretinal Surgeon. He completed an Honors Bachelor of Science, PhD in Pharmaceutical Drug Research, MBA in healthcare management, medical school, ophthalmology residency and a vitreoretinal diseases and surgery fellowship. He is internationally-recognized for his extensive experience in clinical research focused on geographic atrophy, age-related macular degeneration, and has pioneered in introducing novel metrics for evaluating treatment response in AMD. He demonstrated track record in the field of vitreoretinal surgery, including, macular hole surgery, retinal detachment repair, infectious uveitis and endophthalmitis. He has been Principal Investigator in over 75 clinical trials across all phases of development, including trials for Janssen, Genentech/Roche, Allergan, and Regeneron. His work has culminated in authorship on over 200 peer-reviewed papers and over 250 national and international conference and keynote presentations. He has won several awards from the American Society of Retina Specialists (ASRS), American Academy of Ophthalmology (AAO), and is frequently acknowledged in Top Doctor Awards. He serves on numerous national and international clinical trial steering committees and scientific advisory boards and is also the Chief Medical Editor of Eyes on Eyecare.